Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Comment by Nathaniel13on Jan 01, 2021 8:18pm
191 Views
Post# 32208312

RE:2021 will be the year of Medmira!...........................

RE:2021 will be the year of Medmira!...........................Yes indeed we lost our momentum yesterday afternoon no doubt because Sona stole our thunder. I think some of the day traders buying MIR sold at the end of day pushing the SP downward. The MIR longs won't be selling at these levels. Lots of catalysts coming in January; news of FDA & HC notification and commencement of production (likely same release), EU submission and likely very quick granting of CE Mark, and most crucially granting of EUA, which could come within weeks of FDA notification. There is no question that RevealCovid-19 PLUS was created with feedback from the FDA.

If you are a new investor here please buckle up for an exciting 4-6 weeks. Don't get impatient when Sona runs a bit on Monday and please don't pull out and put your money there! The only thing I would do is short them; the  EU is flooded with cheap Chinese made tests. The next critical phase of testing is Antibody with the rollout of vaccines. Medmira is already profitable and with FDA EUA and 50,000 units per day, it becomes a billion dollar company in 2021. I would stake my reputation on it. 
<< Previous
Bullboard Posts
Next >>